UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin

Cancer science, 2002-08, Vol.93 (8), p.874-882

2002

Volltextzugriff (PDF)

Hepatoma‐derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

Cancer science, 2003-12, Vol.94 (12), p.1034-1041

2003

Volltextzugriff (PDF)

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2

Journal of gastroenterology, 2009-03, Vol.44 (3), p.228-235

2009

Volltextzugriff (PDF)

An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study

Journal of clinical rheumatology, 2011-06, Vol.17 (4 Suppl 2), p.S44-S49

2011

Volltextzugriff (PDF)

Hepatoma-derived growth factor is induced in liver regeneration

Hepatology research, 2009-10, Vol.39 (10), p.988-997

2009

Volltextzugriff (PDF)

NS‐398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

International journal of cancer, 2002-06, Vol.99 (5), p.755-761

2002

Volltextzugriff (PDF)

Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study

Journal of clinical rheumatology, 2011-06, Vol.17 (4 Suppl 2), p.S35-S43

2011

Volltextzugriff (PDF)

Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study

Journal of clinical rheumatology, 2011-06, Vol.17 (4 Suppl 2), p.S19-S26

2011

Volltextzugriff (PDF)

Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines

Cancer science, 2004-08, Vol.95 (8), p.666-673

2004

Volltextzugriff (PDF)

IL-18 Up-Regulates Perforin-Mediated NK Activity Without Increasing Perforin Messenger RNA Expression by Binding to Constitutively Expressed IL-18 Receptor

The Journal of immunology (1950), 1999-02, Vol.162 (3), p.1662-1668

1999

Volltextzugriff (PDF)

Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene

Hepatology research, 2007-05, Vol.37 (5), p.360-365

2007

Volltextzugriff (PDF)

IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1- and Th2-cytokines and IL-8

International immunology, 2004-12, Vol.16 (12), p.1733-1739

2004

Volltextzugriff (PDF)

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase‐2 inhibitor

Cancer science, 2006-08, Vol.97 (8), p.768-773

2006

Volltextzugriff (PDF)

Hemochromatosis with Mutation of the Ferroportin 1 (IREG1) Gene

Internal Medicine, 2005, Vol.44(4), pp.285-289

2005

Volltextzugriff (PDF)

Origin of d- and l-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test

Clinica chimica acta, 1999-09, Vol.287 (1), p.145-156

1999

Volltextzugriff (PDF)

Effect of beer on the plasma concentrations of uridine and purine bases

Metabolism, clinical and experimental, 2002-10, Vol.51 (10), p.1317-1323

2002

Volltextzugriff (PDF)

Effect of exercise and beer on the plasma concentration and urinary excretion of purine bases

Journal of rheumatology, 2003-05, Vol.30 (5), p.1036

2003

Volltextzugriff (PDF)

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C

Hepatology research, 2007-05, Vol.37 (5), p.325-330

2007

Volltextzugriff (PDF)

Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout

Metabolism, clinical and experimental, 2001-04, Vol.50 (4), p.393-398

2001

Volltextzugriff (PDF)

Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol

Metabolism, clinical and experimental, 2001-10, Vol.50 (10), p.1230-1233

2001

Volltextzugriff (PDF)

Angiomyolipoma of the liver presenting a homogeneously hypoechoic mass

Journal of gastroenterology, 2005-09, Vol.40 (9), p.916-917

2005

Volltextzugriff (PDF)

Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria

Human genetics, 2001-04, Vol.108 (4), p.279-283

2001

Volltextzugriff (PDF)

Identification of a new point mutation in hypoxanthine phosphoribosyl transferase responsible for hyperuricemia in a female patient

Metabolism, clinical and experimental, 2004-11, Vol.53 (11), p.1500-1502

2004

Volltextzugriff (PDF)

Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy

Metabolism, clinical and experimental, 2003-05, Vol.52 (5), p.605-608

2003

Volltextzugriff (PDF)

An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study

Journal of clinical rheumatology, 2011-06, Vol.17 (4 Suppl 2), p.S13-S18

2011

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(179)

Publikationsform

Artikel
(240)
Berichte
(2)

Sprache

Englisch
(219)
Japanisch
(79)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Humans
(141)
Life Sciences & Biomedicine
(139)
Biological And Medical Sciences
(92)
Male
(73)
Medical Sciences
(72)
Female
(58)
Middle Aged
(56)
Adult
(54)
Aged
(28)
Animals
(25)
Oncology
(25)
Fundamental And Applied Biological Sciences. Psychology
(22)
Medical Laboratory Technology
(21)
Gastroenterology & Hepatology
(20)
Gastroenterology. Liver. Pancreas. Abdomen
(19)
Mice
(17)
Pharmacology. Drug Treatments
(17)
Endocrinology & Metabolism
(16)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin

Hepatoma‐derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2

An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study

Hepatoma-derived growth factor is induced in liver regeneration

NS‐398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study

Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study

Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines

IL-18 Up-Regulates Perforin-Mediated NK Activity Without Increasing Perforin Messenger RNA Expression by Binding to Constitutively Expressed IL-18 Receptor

Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene

IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1- and Th2-cytokines and IL-8

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase‐2 inhibitor

Hemochromatosis with Mutation of the Ferroportin 1 (IREG1) Gene

Origin of d- and l-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test

Effect of beer on the plasma concentrations of uridine and purine bases

Effect of exercise and beer on the plasma concentration and urinary excretion of purine bases

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C

Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout

Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol

Angiomyolipoma of the liver presenting a homogeneously hypoechoic mass

Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria

Identification of a new point mutation in hypoxanthine phosphoribosyl transferase responsible for hyperuricemia in a female patient

Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy

An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study

Suchergebnisse filtern